Ina Jeong

902 total citations
33 papers, 507 citations indexed

About

Ina Jeong is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ina Jeong has authored 33 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Ina Jeong's work include Tuberculosis Research and Epidemiology (9 papers), Infectious Diseases and Tuberculosis (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Ina Jeong is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Infectious Diseases and Tuberculosis (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Ina Jeong collaborates with scholars based in South Korea, United States and Ethiopia. Ina Jeong's co-authors include Ji Yeon Lee, Joon-Sung Joh, Yeonjae Kim, Gayeon Kim, Hyoung‐Shik Shin, Jae Ho Lee, Ho Il Yoon, Choon‐Taek Lee, Junghan Song and Jong Sun Park and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and International Journal of Environmental Research and Public Health.

In The Last Decade

Ina Jeong

30 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ina Jeong South Korea 11 302 92 91 70 51 33 507
Jinguo Chu China 8 308 1.0× 87 0.9× 43 0.5× 126 1.8× 94 1.8× 17 547
Falk Fichtner Germany 13 351 1.2× 97 1.1× 151 1.7× 152 2.2× 50 1.0× 25 686
Radhika Venugopal India 5 278 0.9× 121 1.3× 87 1.0× 128 1.8× 49 1.0× 8 477
Tai Nin Chau China 7 268 0.9× 75 0.8× 49 0.5× 103 1.5× 51 1.0× 8 492
Gui‐Qiang Wang China 7 539 1.8× 224 2.4× 76 0.8× 229 3.3× 92 1.8× 11 979
Zhiguo Zhou China 10 165 0.5× 52 0.6× 36 0.4× 87 1.2× 42 0.8× 16 289
Selçuk Yaylacı Türkiye 14 285 0.9× 75 0.8× 31 0.3× 108 1.5× 74 1.5× 94 613
Hongzhou Lu China 6 265 0.9× 62 0.7× 21 0.2× 112 1.6× 60 1.2× 11 423
Jiangshan Lian China 10 255 0.8× 125 1.4× 26 0.3× 163 2.3× 75 1.5× 35 505

Countries citing papers authored by Ina Jeong

Since Specialization
Citations

This map shows the geographic impact of Ina Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Jeong more than expected).

Fields of papers citing papers by Ina Jeong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Jeong. The network helps show where Ina Jeong may publish in the future.

Co-authorship network of co-authors of Ina Jeong

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Jeong. A scholar is included among the top collaborators of Ina Jeong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Jeong. Ina Jeong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lee, Ji Yeon, et al.. (2024). Identifying Predictors of Unfavorable Treatment Outcomes in Tuberculosis Patients. International Journal of Environmental Research and Public Health. 21(11). 1454–1454. 2 indexed citations
4.
Yoon, Bo Hyun, Jin Woo Lee, Ina Jeong, et al.. (2024). Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Microvascular Research. 155. 104698–104698. 1 indexed citations
5.
Chin, Bum Sik, et al.. (2023). Predictive Factors and Clinical Impacts of Delayed Isolation of Tuberculosis during Hospital Admission. Journal of Clinical Medicine. 12(4). 1361–1361. 1 indexed citations
6.
Yeo, Yohwan, Ji Yeon Lee, Ina Jeong, et al.. (2022). Prognostic Factors for Pulmonary Fibrosis Following Pneumonia in Patients with COVID-19: A Prospective Study. Journal of Clinical Medicine. 11(19). 5913–5913. 6 indexed citations
7.
Jeong, Ina, Mona Alotaibi, Timothy M. Fernandes, et al.. (2022). Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy. Pulmonary Circulation. 12(3). e12110–e12110. 18 indexed citations
8.
Kim, Sang Hyuk, Changhwan Kim, Ina Jeong, et al.. (2021). Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry. Frontiers in Medicine. 8. 722124–722124. 9 indexed citations
9.
Lee, Ji Yeon, Byoung-Jun Kim, Byoung-Jun Kim, et al.. (2020). Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis. Diagnostics. 10(11). 991–991. 1 indexed citations
10.
Jeong, Ina, Jaehyun Lim, Dong Kyu Oh, Woo Jin Kim, & Yeon‐Mok Oh. (2018). Gene expression profile of human lung in a relatively early stage of COPD with emphysema. International Journal of COPD. Volume 13. 2643–2655. 24 indexed citations
11.
Sim, Yun Su, Jin Hwa Lee, Ki Uk Kim, et al.. (2017). Determinants of Nicotine Dependence in Chronic Obstructive Pulmonary Disease. Tuberculosis & respiratory diseases. 80(3). 277–277. 5 indexed citations
12.
Lee, Ji Yeon, Jongbin Kim, Eun Hee Chung, et al.. (2017). The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infectious Diseases. 17(1). 498–498. 65 indexed citations
13.
Rhee, Chin Kook, Ji Ye Jung, Sei Won Lee, et al.. (2016). The Korean Cough Guideline: Recommendation and Summary Statement. Tuberculosis & respiratory diseases. 79(1). 14–14. 21 indexed citations
14.
Lee, Ji Yeon, Gayeon Kim, Dong‐Gyun Lim, et al.. (2016). Seroprevalence of Middle East Respiratory Syndrome Coronavirus Among Healthcare Personnel Caring for Patients With Middle East Respiratory Syndrome in South Korea. Infection Control and Hospital Epidemiology. 37(12). 1513–1514. 4 indexed citations
15.
Lee, Ji Yeon, et al.. (2015). Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clinical Immunology. 159(1). 37–46. 8 indexed citations
16.
Cha, Ran‐hui, Joon-Sung Joh, Ina Jeong, et al.. (2015). Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital. Journal of Korean Medical Science. 30(12). 1807–1807. 66 indexed citations
17.
Jeong, Ina, Seok Won Kim, Soo Yeon Park, et al.. (2014). Pulmonary Cryptococcosis That Mimicked Rheumatoid Nodule in Rheumatoid Arthritis Lesion. Tuberculosis & respiratory diseases. 77(6). 266–266. 3 indexed citations
18.
Jeong, Ina, et al.. (2013). Klebsiella pneumoniae Liver Abscess Complicated With Septic Pulmonary Embolism. Journal of the Korean Geriatrics Society. 17(4). 239–243. 1 indexed citations
19.
Koo, Hyeon‐Kyoung, Ji Sun Lee, Sun Mi Choi, et al.. (2012). Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 17(5). 808–813. 23 indexed citations
20.
Jeong, Ina, Eun Young Heo, Jae Seok Lee, et al.. (2009). Streptococcus salivarius pneumonia with pulmonary nocardiosis in a rheumatoid arthritis patient treated with immunosuppressants. The Korean Journal of Internal Medicine. 77(1). 128–132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinguo Chu Breakdown of academic impact, for papers by Falk Fichtner Breakdown of academic impact, for papers by Radhika Venugopal Breakdown of academic impact, for papers by Tai Nin Chau Breakdown of academic impact, for papers by Gui‐Qiang Wang Breakdown of academic impact, for papers by Zhiguo Zhou Breakdown of academic impact, for papers by Selçuk Yaylacı Breakdown of academic impact, for papers by Hongzhou Lu Breakdown of academic impact, for papers by Jiangshan Lian
Rankless by CCL
2026